Explore Trades
All Companies

AZN

AstraZeneca PLC

$173.3updated Jul 30, 2026

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Total Trades

15

Politicians Trading

6

Last Traded

Mar 31, 2026

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
Alan ArmstrongRJul 21, 2026Mar 31, 2026Buy$1,001 - $15,000-12.13%
Alan ArmstrongRJul 21, 2026Mar 30, 2026Buy$15,001 - $50,000-10.61%
Gilbert Ray Cisneros, Jr.DJan 12, 2026Dec 18, 2025Buy$1,001 - $15,000+91.26%
Julia LetlowRJan 13, 2026Dec 8, 2025Buy$1,001 - $15,000+89.86%
Gilbert Ray Cisneros, Jr.DDec 15, 2025Nov 19, 2025Buy$1,001 - $15,000+94.74%
Lisa C. McClainRNov 21, 2025Oct 31, 2025Sell$1,001 - $15,000+110.32%
Lisa C. McClainRNov 21, 2025Oct 30, 2025Sell$1,001 - $15,000+110.47%
Lisa C. McClainRNov 21, 2025Oct 30, 2025Buy$1,001 - $15,000+110.47%
Gilbert Ray Cisneros, Jr.DNov 18, 2025Oct 21, 2025Buy$1,001 - $15,000+108.24%
Val T. HoyleDOct 10, 2025Sep 23, 2025Sell$1,001 - $15,000+128.12%
Lisa C. McClainRAug 13, 2025Jul 22, 2025Buy$1,001 - $15,000+145.89%
Lisa C. McClainRAug 13, 2025Jun 17, 2025Sell$1,001 - $15,000+144.19%
Lisa C. McClainRAug 13, 2025Jun 9, 2025Buy$1,001 - $15,000+137.36%
Bruce WestermanRMay 12, 2025Apr 21, 2025Sell$1,001 - $15,000+159.04%
Bruce WestermanRApr 16, 2025Mar 3, 2025Buy$1,001 - $15,000+127.73%